新生儿Noonan综合征1例并文献复习
A Case Report of Noonan Syndrome in Newborn Infant and Literature Review
DOI: 10.12677/acm.2024.14123188, PDF,   
作者: 冯婷婷, 沈 鑫:山东第一医科大学附属省立医院全科医学科,山东 济南;李尚滨*:山东第一医科大学附属省立医院全科医学科,山东 济南;山东第一医科大学附属省立医院老年医学科,山东 济南
关键词: Noonan综合征遗传性疾病特殊面容新生儿Noonan Syndrome Hereditary Disorders Special Facial Features Neonatal
摘要: Noonan综合征(NS)是一种丝裂原活化蛋白激酶信号传导通路(RAS-MAPK)相关基因突变导致的一种遗传性疾病,以常染色体显性遗传为主,个别基因突变会导致常染色体隐性遗传。目前国内针对NS的诊治仍然缺乏经验,诊断大多依赖患者随年龄增长而逐渐明显的临床特征以及NS相关基因检测。这就意味着在临床工作中可能无法及时发现并作出诊断,无法尽早对NS的疾病进展做出有效干预,以致当患者因各种NS相关并发症就诊时,已经产生了无法逆转的器质性损害。本文中我们对山东第一医科大学附属省立医院收治的1例新生儿Noonan综合征的患者进行回顾性分析并针对相关文献进行复习归纳。旨在为临床工作者提供早期识别诊断的经验,提高临床医生对于NS的认知水平与了解。
Abstract: Noonan syndrome (NS) is a hereditary disease caused by mutations in genes related to the RAS-mitogen-activated protein kinase signalling pathway (RAS-MAPK), which is predominantly inherited in an autosomal dominant manner, with individual mutations leading to autosomal recessive inheritance. At present, there is still a lack of experience in the diagnosis and treatment of NS in China, and most of the diagnosis relies on the clinical features of the patient that become obvious with age and the NS-related gene test. This means that it may not be possible to detect and diagnose NS in time and intervene in the disease progression of NS as early as possible, so that by the time the patient seeks treatment for various NS-related complications, irreversible organic damage has already occurred. A case of neonatal Noonan syndrome admitted to the Provincial Hospital of Shandong First Medical University was retrospectively analysed and the relevant literature was reviewed and summarized. The aim is to provide clinicians with relevant diagnostic experience and improve their knowledge and understanding of NS.
文章引用:冯婷婷, 沈鑫, 李尚滨. 新生儿Noonan综合征1例并文献复习[J]. 临床医学进展, 2024, 14(12): 1072-1077. https://doi.org/10.12677/acm.2024.14123188

参考文献

[1] Romano, A.A., Allanson, J.E., Dahlgren, J., Gelb, B.D., Hall, B., Pierpont, M.E., et al. (2010) Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines. Pediatrics, 126, 746-759. [Google Scholar] [CrossRef] [PubMed]
[2] Cesur Aydin, K. and Ozcan, I. (2008) Noonan Syndrome: A Review. Minerva Pediatrics, 60, 343-346.
[3] Roberts, A.E., Allanson, J.E., Tartaglia, M. and Gelb, B.D. (2013) Noonan Syndrome. The Lancet, 381, 333-342. [Google Scholar] [CrossRef] [PubMed]
[4] Bhambhani, V. and Muenke, M. (2014) Noonan Syndrome. American Family Physician, 89, 37-43.
[5] Tafazoli, A., Eshraghi, P., Koleti, Z.K. and Abbaszadegan, M. (2017) Noonan Syndrome—A New Survey. Archives of Medical Science, 1, 215-220. [Google Scholar] [CrossRef] [PubMed]
[6] 李辛, 王秀敏, 王剑, 傅立军, 罗小平, 傅君芬, 沈亦平. Noonan综合征的临床实践指南[Z]. 2022-03-10.
[7] Chen, Q., Hong, D., Huang, Y., Zhang, Z. and Wang, S. (2024) Phenotypic and Genotypic Spectrum of Noonan Syndrome: A Retrospective Analysis of 46 Consecutive Pediatric Patients Presented at a Regional Cardiac Center in China. Heliyon, 10, e27038. [Google Scholar] [CrossRef] [PubMed]
[8] Leoni, C., Blandino, R., Delogu, A.B., De Rosa, G., Onesimo, R., Verusio, V., et al. (2021) Genotype‐Cardiac Phenotype Correlations in a Large Single‐Center Cohort of Patients Affected by Rasopathies: Clinical Implications and Literature Review. American Journal of Medical Genetics Part A, 188, 431-445. [Google Scholar] [CrossRef] [PubMed]
[9] Sarkozy, A., Carta, C., Moretti, S., Zampino, G., Digilio, M.C., Pantaleoni, F., et al. (2009) Germline BRAF Mutations in Noonan, LEOPARD, and Cardiofaciocutaneous Syndromes: Molecular Diversity and Associated Phenotypic Spectrum. Human Mutation, 30, 695-702. [Google Scholar] [CrossRef] [PubMed]
[10] Hebron, K.E., Hernandez, E.R. and Yohe, M.E. (2022) The RASopathies: From Pathogenetics to Therapeutics. Disease Models & Mechanisms, 15, dmm049107. [Google Scholar] [CrossRef] [PubMed]
[11] Komatsuzaki, S., Aoki, Y., Niihori, T., Okamoto, N., Hennekam, R.C.M., Hopman, S., et al. (2010) Mutation Analysis of the SHOC2 Gene in Noonan-Like Syndrome and in Hematologic Malignancies. Journal of Human Genetics, 55, 801-809. [Google Scholar] [CrossRef] [PubMed]
[12] Tartaglia, M., Gelb, B.D. and Zenker, M. (2011) Noonan Syndrome and Clinically Related Disorders. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 161-179. [Google Scholar] [CrossRef] [PubMed]
[13] Ekvall, S., Wilbe, M., Dahlgren, J., Legius, E., van Haeringen, A., Westphal, O., et al. (2015) Mutation in NRAS in Familial Noonan Syndrome—Case Report and Review of the Literature. BMC Medical Genetics, 16, Article No. 95. [Google Scholar] [CrossRef] [PubMed]
[14] Johnston, J.J., van der Smagt, J.J., Rosenfeld, J.A., Pagnamenta, A.T., Alswaid, A., Baker, E.H., et al. (2018) Autosomal Recessive Noonan Syndrome Associated with Biallelic LZTR1 Variants. Genetics in Medicine, 20, 1175-1185. [Google Scholar] [CrossRef] [PubMed]
[15] Busley, A.V., Gutiérrez-Gutiérrez, Ó., Hammer, E., Koitka, F., Mirzaiebadizi, A., Steinegger, M., et al. (2024) Mutation-induced LZTR1 Polymerization Provokes Cardiac Pathology in Recessive Noonan Syndrome. Cell Reports, 43, Article ID: 114448. [Google Scholar] [CrossRef] [PubMed]
[16] Beukers, W., Hercegovac, A. and Zwarthoff, E.C. (2013) HRAS Mutations in Bladder Cancer at an Early Age and the Possible Association with the Costello Syndrome. European Journal of Human Genetics, 22, 837-839. [Google Scholar] [CrossRef] [PubMed]
[17] Aly, S.A., Boyer, K.M., Muller, B.A., Marini, D., Jones, C.H. and Nguyen, H.H. (2020) Complicated Ventricular Arrhythmia and Hematologic Myeloproliferative Disorder in RIT1‐Associated Noonan Syndrome: Expanding the Phenotype and Review of the Literature. Molecular Genetics & Genomic Medicine, 8, e1253. [Google Scholar] [CrossRef] [PubMed]
[18] Kouz, K., Lissewski, C., Spranger, S., Mitter, D., Riess, A., Lopez-Gonzalez, V., et al. (2016) Genotype and Phenotype in Patients with Noonan Syndrome and a RIT1 Mutation. Genetics in Medicine, 18, 1226-1234. [Google Scholar] [CrossRef] [PubMed]
[19] Onore, M.E., Caiazza, M., Farina, A., Scarano, G., Budillon, A., Borrelli, R.N., et al. (2023) A Novel Homozygous Loss-of-Function Variant in SPRED2 Causes Autosomal Recessive Noonan-Like Syndrome. Genes, 15, Article No. 32. [Google Scholar] [CrossRef] [PubMed]